Discovery of a novel compound: Insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death

Yuzo Nakagawa-Yagi, Dong Kug Choi, Nobuo Ogane, Shin Ichi Shimada, Motohide Seya, Takashi Momoi, Takashi Ito, Yoshiyuki Sakaki

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The exposure of humans and experimental animals to certain industrial toxins such as acrylamide is known to cause nerve damage classified as axonopathy, but the mechanisms involved are poorly understood. Here we show that acrylamide induces morphological changes and tyrosine phosphorylation of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), a member of the FAK subfamily, in human differentiating neuroblastoma SH-SY5Y cells. Furthermore, we identified a novel molecule designated 'compound-1' that inhibits the morphological and biochemical events. Daily oral administrations of the compound also effectively alleviated behavioral deficits in animals elicited by acrylamide in inclined plane testing, landing foot spread testing and rota-rod performance testing. The compound also effectively inhibited the biological and biochemical responses caused by another axonopathy inducer, colchicine, including tyrosine phosphorylation of Pyk2, formation of an 85-kDa poly(ADP-ribose)polymerase (PARP) fragment and apoptosis-associated induction of the NAPOR gene as well as neuronal cell death. Our findings not only provide insight into FAK and Pyk2 functions in neuronal cells, but may also be important in the development of therapeutic agents for peripheral neuropathy and neurodegeneration

Original languageEnglish
Pages (from-to)8-19
Number of pages12
JournalBrain Research
Volume909
Issue number1-2
DOIs
Publication statusPublished - Aug 3 2001
Externally publishedYes

Fingerprint

Focal Adhesion Kinase 2
Focal Adhesion Protein-Tyrosine Kinases
Acrylamide
Colchicine
Cell Death
Tyrosine
Phosphorylation
Poly(ADP-ribose) Polymerases
Peripheral Nervous System Diseases
Neuroblastoma
Oral Administration
Foot
Apoptosis
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Discovery of a novel compound : Insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death. / Nakagawa-Yagi, Yuzo; Choi, Dong Kug; Ogane, Nobuo; Shimada, Shin Ichi; Seya, Motohide; Momoi, Takashi; Ito, Takashi; Sakaki, Yoshiyuki.

In: Brain Research, Vol. 909, No. 1-2, 03.08.2001, p. 8-19.

Research output: Contribution to journalArticle

Nakagawa-Yagi, Yuzo ; Choi, Dong Kug ; Ogane, Nobuo ; Shimada, Shin Ichi ; Seya, Motohide ; Momoi, Takashi ; Ito, Takashi ; Sakaki, Yoshiyuki. / Discovery of a novel compound : Insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death. In: Brain Research. 2001 ; Vol. 909, No. 1-2. pp. 8-19.
@article{b69644780e0c4e9fb66eb7b0823ef927,
title = "Discovery of a novel compound: Insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death",
abstract = "The exposure of humans and experimental animals to certain industrial toxins such as acrylamide is known to cause nerve damage classified as axonopathy, but the mechanisms involved are poorly understood. Here we show that acrylamide induces morphological changes and tyrosine phosphorylation of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), a member of the FAK subfamily, in human differentiating neuroblastoma SH-SY5Y cells. Furthermore, we identified a novel molecule designated 'compound-1' that inhibits the morphological and biochemical events. Daily oral administrations of the compound also effectively alleviated behavioral deficits in animals elicited by acrylamide in inclined plane testing, landing foot spread testing and rota-rod performance testing. The compound also effectively inhibited the biological and biochemical responses caused by another axonopathy inducer, colchicine, including tyrosine phosphorylation of Pyk2, formation of an 85-kDa poly(ADP-ribose)polymerase (PARP) fragment and apoptosis-associated induction of the NAPOR gene as well as neuronal cell death. Our findings not only provide insight into FAK and Pyk2 functions in neuronal cells, but may also be important in the development of therapeutic agents for peripheral neuropathy and neurodegeneration",
author = "Yuzo Nakagawa-Yagi and Choi, {Dong Kug} and Nobuo Ogane and Shimada, {Shin Ichi} and Motohide Seya and Takashi Momoi and Takashi Ito and Yoshiyuki Sakaki",
year = "2001",
month = "8",
day = "3",
doi = "10.1016/S0006-8993(01)02608-7",
language = "English",
volume = "909",
pages = "8--19",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Discovery of a novel compound

T2 - Insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death

AU - Nakagawa-Yagi, Yuzo

AU - Choi, Dong Kug

AU - Ogane, Nobuo

AU - Shimada, Shin Ichi

AU - Seya, Motohide

AU - Momoi, Takashi

AU - Ito, Takashi

AU - Sakaki, Yoshiyuki

PY - 2001/8/3

Y1 - 2001/8/3

N2 - The exposure of humans and experimental animals to certain industrial toxins such as acrylamide is known to cause nerve damage classified as axonopathy, but the mechanisms involved are poorly understood. Here we show that acrylamide induces morphological changes and tyrosine phosphorylation of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), a member of the FAK subfamily, in human differentiating neuroblastoma SH-SY5Y cells. Furthermore, we identified a novel molecule designated 'compound-1' that inhibits the morphological and biochemical events. Daily oral administrations of the compound also effectively alleviated behavioral deficits in animals elicited by acrylamide in inclined plane testing, landing foot spread testing and rota-rod performance testing. The compound also effectively inhibited the biological and biochemical responses caused by another axonopathy inducer, colchicine, including tyrosine phosphorylation of Pyk2, formation of an 85-kDa poly(ADP-ribose)polymerase (PARP) fragment and apoptosis-associated induction of the NAPOR gene as well as neuronal cell death. Our findings not only provide insight into FAK and Pyk2 functions in neuronal cells, but may also be important in the development of therapeutic agents for peripheral neuropathy and neurodegeneration

AB - The exposure of humans and experimental animals to certain industrial toxins such as acrylamide is known to cause nerve damage classified as axonopathy, but the mechanisms involved are poorly understood. Here we show that acrylamide induces morphological changes and tyrosine phosphorylation of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), a member of the FAK subfamily, in human differentiating neuroblastoma SH-SY5Y cells. Furthermore, we identified a novel molecule designated 'compound-1' that inhibits the morphological and biochemical events. Daily oral administrations of the compound also effectively alleviated behavioral deficits in animals elicited by acrylamide in inclined plane testing, landing foot spread testing and rota-rod performance testing. The compound also effectively inhibited the biological and biochemical responses caused by another axonopathy inducer, colchicine, including tyrosine phosphorylation of Pyk2, formation of an 85-kDa poly(ADP-ribose)polymerase (PARP) fragment and apoptosis-associated induction of the NAPOR gene as well as neuronal cell death. Our findings not only provide insight into FAK and Pyk2 functions in neuronal cells, but may also be important in the development of therapeutic agents for peripheral neuropathy and neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=0035800625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035800625&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(01)02608-7

DO - 10.1016/S0006-8993(01)02608-7

M3 - Article

C2 - 11478917

AN - SCOPUS:0035800625

VL - 909

SP - 8

EP - 19

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -